Do you want to read an article? Please log in or register.
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04-2021) trial
Lung, Respiratory and Thoracic Cancer
